List view / Grid view
With temperatures regularly reaching -70°C, the coldest place on earth is unsurprisingly the Antarctic. Source BioScience is now able to replicate these bone-chilling temperatures in an innovative, efficient storage solution.
18 January 2016 | By Victoria White
The FDA has accepted for Priority Review Eisai’s supplemental New Drug Application for lenvatinib for the potential treatment of patients with renal cell carcinoma...
18 January 2016 | By Victoria White
Benepali is the first etanercept biosimilar referencing Enbrel to be approved in the EU, making it the first subcutaneous anti-TNF biosimilar available there...
18 January 2016 | By Victoria White
Cosentyx (secukinumab) is a fully human monoclonal antibody that selectively neutralizes circulating interleukin-17A (IL-17A)...
18 January 2016 | By Victoria White
In a statement, The University Hospital of Rennes confirmed that five other participants in the clinical trial remain in a stable condition...
18 January 2016 | By Victoria White
Autologous haematopoietic stem cell transplantation (AHSCT), developed at Sheffield Teaching Hospitals, has shown 'remarkable' results in patients with MS...
14 January 2016 | By DiscoveRx
DiscoveRx Corporation announced the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays...
14 January 2016 | By Victoria White
The company states that the growth will be primarily down to the introduction of Telesta Therapeutics MCNA and Roche’s atezolizumab in 2016 and Bristol-Myers Squibb’s Opdivoin 2017...
14 January 2016 | By
The TERRAIN study achieved its primary endpoint demonstrating a statistically significant increase in progression-free survival for enzalutamide compared to bicalutamide...
14 January 2016 | By Victoria White
VAL-083 is a first-in-class small molecule chemotherapy that readily crosses the blood brain barrier...
13 January 2016 | By Victoria White
The RSV treatment market will rise from approximately $640 million in 2014 to over $2.3 billion by 2024, says research and consulting firm GlobalData...
13 January 2016 | By Victoria White
To sustain progress made in eradicating polio to date, and tto protect all children from the disease, experts say $1.5 billion is urgently needed...
13 January 2016 | By Victoria White
The new guidance combines clinical advice and public health guidance for the first time...
13 January 2016 | By Victoria White
IONIS-HBV-LRx (previously referred to as ISIS-GSK6-LRx) is a drug Ionis is developing with GSK for the treatment of patients with hepatitis B virus...
13 January 2016 | By Victoria White
The glioblastoma treatment market will increase fivefold from $659 million in 2014 to $3.3 billion by 2024, according to research and consulting firm GlobalData...
